Daniel Davidzon joins as Marketing Manager, Stacey Paterson (Registered Nurse) appointed to Health and Innovation Advisory Board
TORONTO, Aug. 28, 2018 /CNW/ - Cannvas MedTech Inc. ("Cannvas" or the "Company") (CSE: MTEC, Frankfurt: 3CM), a leading business technology company in the cannabis space, is pleased to announce that the company has exceeded quarterly growth targets and has tripled its number of employees in 2018. Growth in key departments with highly skilled individuals allows Cannvas to remain focused on pushing forward with its first product offering for the global cannabis markets: Cannvas.me, a global cannabis education platform.
The Company's most recent hire is David Davidzon, an accomplished brand strategist and creative writer with deep roots in the food and beverage industry, with over 10 years' experience in corporate branding communications and public relations, digital marketing and social media, joins Cannvas as Marketing Manager. The Company also announces the appointment of Stacey Paterson (Registered Nurse) to its Health and Innovation Advisory Board. Paterson joins Daniel J. Bal, MD and Shirish Patel, MD also recently appointed to the board which oversees content related to the Cannvas.me platform.
"I am very pleased to welcome two outstanding individuals David Davidzon and Ms. Stacey Paterson (Registered Nurse) to our Company," said Steve Loutskou, Chief Operating Officer, Global Markets, Cannvas MedTech Inc. "Mr. Davidzon is a highly skilled brand strategist that brings with him a depth of experience to our marketing team. Ms. Paterson brings to our panel unique insights from emergency rooms of the Canadian hospital system, from years of experience from dealing with real patient needs. Our recent appointments will work to keep our articles, education modules, and interactive support technologies relevant for the Canadian Cannabis Community. It takes great people to make a great product and we have accelerated our growth to ensure the timely launch of Cannvas.me. I look forward to working with David and Stacey as we prepare to launch the Cannvas.me platform and transform the medical cannabis landscape."
David Davidzon has worked with Luminato, BMO, The Royal Conservatory of Music and Canadian subsidiary of Aroma Espresso Bar, developing and successfully executing promotional campaigns, procuring strategic partnerships and managing live events with high-profile artists. As a skilled storyteller and avid consumer of popular culture, Daniel does his best to sneak his personal interests into professional endeavours, resulting in memorable national campaigns and taglines.
As a member of the Health and Innovation Advisory Board Ms. Paterson will participate in the review of content to be published on platform, oversee research studies and provide insight from an ICU nurse and clinical perspective. Ms.Paterson currently works as an Intensive Care Nurse at several Greater Toronto Area hospitals and has specialized working on the neurology, medical/surgical/transplant, cardiac and critical care units. She holds a Bachelor of Nursing from the University of New Brunswick plus Certificates in Critical Care and Nephrology.
About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.
For additional information:
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company's Management's Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.
SOURCE Cannvas MedTech Inc.
For further information: Media Inquiries: email@example.com; Investor Relations: firstname.lastname@example.org, 1-800-489-0116